Received Mar 13, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Triggered autoimmune disease; This serious case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a adult female patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced autoimmune disorder (Verbatim: Triggered autoimmune disease) (serious criteria GSK medically significant). The outcome of the autoimmune disorder was not resolved. The reporter considered the autoimmune disorder to be related to Shingles vaccine. The company considered the autoimmune disorder to be related to Shingles vaccine. Additional Information: GSK Receipt Date: 07-MAR-2026 This case was reported by a patient via interactive digital media. The patient stated to read side effects. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Autoimmune disorder, an unknown time after receiving Shingles vaccine, in an adult female patient. Based on the available information, a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow-up has not been received.